[1]
Datta, N.R. et al. 2018. Clinical estimation of α/β values for prostate cancer from isoeffective phase III randomized trials with moderately hypofractionated radiotherapy. Acta Oncologica. 57, 7 (Jul. 2018), 883–894. DOI:https://doi.org/10.1080/0284186X.2018.1433874.